These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1490693

  • 1. Value of fasting blood glucose and serum fructosamine as a measure of diabetic control in non-insulin-dependent diabetes mellitus.
    Kruseman AC, Mercelina L, Degenaar CP.
    Horm Metab Res Suppl; 1992; 26():59-62. PubMed ID: 1490693
    [Abstract] [Full Text] [Related]

  • 2. [Levels of fasting blood glucose and serum fructosamine for monitoring of glucose control in patients with non-insulin-dependent diabetes mellitus].
    Mercelina LF, Degenaar CP, Nieuwenhuijzen Kruseman AC.
    Ned Tijdschr Geneeskd; 1989 Sep 23; 133(38):1887-90. PubMed ID: 2797305
    [Abstract] [Full Text] [Related]

  • 3. Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management.
    Baker JR, Johnson RN, Scott DJ.
    Br Med J (Clin Res Ed); 1984 May 19; 288(6429):1484-6. PubMed ID: 6426612
    [Abstract] [Full Text] [Related]

  • 4. Fructosamine: an alternative assessment of past glycaemic control in developing countries.
    Islam N, Akhter J, Kayani N, Khan MA.
    J Pak Med Assoc; 1993 Nov 19; 43(11):238-40. PubMed ID: 8114262
    [Abstract] [Full Text] [Related]

  • 5. Serum fructosamine in patients with diabetes mellitus.
    Baker J, Reid I, Holdaway I.
    N Z Med J; 1985 Jul 10; 98(782):532-5. PubMed ID: 3861965
    [Abstract] [Full Text] [Related]

  • 6. [Determination of fasting blood glucose and serum fructosamine levels for the assessment of glucose regulation in patients with non-insulin dependent diabetes mellitus].
    van Haeften TW, Walstra SM, Rustemeijer C.
    Ned Tijdschr Geneeskd; 1989 Nov 25; 133(47):2356-7. PubMed ID: 2586671
    [No Abstract] [Full Text] [Related]

  • 7. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level.
    Tahara Y, Shima K.
    Diabetes Care; 1995 Apr 25; 18(4):440-7. PubMed ID: 7497851
    [Abstract] [Full Text] [Related]

  • 8. [Critical evaluation of fructosamine as a control parameter in the assessment of diabetic metabolic regulation].
    Hay U, Sedlmayer A, Müller MM, Dorda W, Schernthaner G.
    Klin Wochenschr; 1989 Apr 03; 67(7):379-85. PubMed ID: 2747138
    [Abstract] [Full Text] [Related]

  • 9. Serum fructosamine/haemoglobin A1 ratio predicts the future changes in haemoglobin A1 in type 2 (non-insulin dependent) diabetic patients.
    MacRury SM, Kilpatrick ES, Paterson KR, Dominiczak MH.
    Clin Chim Acta; 1991 May 31; 199(1):51-8. PubMed ID: 1934502
    [Abstract] [Full Text] [Related]

  • 10. The clinical usefulness of serum fructosamine and HbAlc in patients with NIDDM.
    Lim SY, Jhoo YM, Lee SS, Lee MH, Chung ES, Lee SJ.
    Korean J Intern Med; 1989 Jul 31; 4(2):155-9. PubMed ID: 2486845
    [Abstract] [Full Text] [Related]

  • 11. [Diagnosis of the diabetic metabolic status using fructosamine (and HbA1c) determination. The glycation quotient Glyc-Q, the glycation nomogram].
    Henrichs HR.
    Wien Klin Wochenschr Suppl; 1990 Jul 31; 180():64-9; discussion 78-81. PubMed ID: 2321396
    [Abstract] [Full Text] [Related]

  • 12. Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine.
    Rosediani M, Azidah AK, Mafauzy M.
    Med J Malaysia; 2006 Mar 31; 61(1):67-71. PubMed ID: 16708736
    [Abstract] [Full Text] [Related]

  • 13. Plasma albumin concentration is a predictor of HbA1c among type 2 diabetic patients, independently of fasting plasma glucose and fructosamine.
    Rodríguez-Segade S, Rodríguez J, Mayan D, Camiña F.
    Diabetes Care; 2005 Feb 31; 28(2):437-9. PubMed ID: 15677811
    [No Abstract] [Full Text] [Related]

  • 14. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ.
    Nephrology (Carlton); 2012 Feb 31; 17(2):182-8. PubMed ID: 21883672
    [Abstract] [Full Text] [Related]

  • 15. Fructosamine cannot replace HbA1c in the management of type 2 diabetes (NIDDM).
    Furuseth K, Bruusgaard D, Rutle O, Vaaler S.
    Scand J Prim Health Care; 1994 Sep 31; 12(3):219-24. PubMed ID: 7997703
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of HbA1c, fructosamine and the main metabolic parameters in a non-insulin-dependent diabetic population].
    Magnati G, Arsenio L, Baroni MC, Bodria P, Bossi S, Delsignore R, Ippolito L, Mineo F, Strata A.
    G Clin Med; 1990 Jan 31; 71(1):25-30. PubMed ID: 2365166
    [Abstract] [Full Text] [Related]

  • 17. Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis.
    Trenti T, Cristani A, Cioni G, Pentore R, Mussini C, Ventura E.
    Ric Clin Lab; 1990 Jan 31; 20(4):261-7. PubMed ID: 2075378
    [Abstract] [Full Text] [Related]

  • 18. Comparison of serum fructosamine and blood glucose concentrations as indices of glycaemic control in non-insulin dependent diabetic out-patients.
    Lim TO, Selvan T, Suppiah A, Khan N, Ismail F.
    Singapore Med J; 1992 Jun 31; 33(3):287-9. PubMed ID: 1631590
    [Abstract] [Full Text] [Related]

  • 19. [Comparison of screening methods for diabetes mellitus, based on fasting glucose, HbA1C and fructosamine levels].
    Sasaki A, Matsumiya K, Arao M, Hasegawa K, Horiuchi N.
    Rinsho Byori; 1991 Jan 31; 39(1):91-6. PubMed ID: 2008048
    [Abstract] [Full Text] [Related]

  • 20. [Fructosamine and HbA1c during monitoring of glucose levels in diabetes].
    Dezier JF, Barbier P, Le Treut A, Allannic H.
    Diabete Metab; 1988 Jan 31; 14(5):635-40. PubMed ID: 3234587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.